The Flyte subsidiary's revenue ramp ($1.0M+ H1, guided ~$760K Q2 with 150% QoQ growth) is the primary value driver for VTAK, but the parent's core medical device business is pre-revenue and the $2M market cap makes this a high-risk micro-cap.
Price Chart
Executive Summary
Catheter Precision subsidiary Flyte reported $1.0M+ in H1 2026 revenue from its digital private aviation booking platform, with 1,000+ new users and 118 flights. The company guided for ~$760K in Q2 Flyte revenue and a 150% QoQ increase, but the parent's core medical device business remains pre-revenue or minimal, and the $2M market cap makes this a micro-cap story stock with high execution risk.
Key Financial Metrics
Key Facts
- Flyte subsidiary generated $1.0M+ in H1 2026 revenue from its digital private aviation booking platform.
- Flyte acquired 1,000+ new platform users and facilitated 118 flights in H1 2026.
- Company guided for ~$760K in Q2 2026 Flyte revenue and a 150% QoQ increase.
- Catheter Precision's core medical device business remains pre-revenue or minimal — the press release focuses entirely on the Flyte aviation subsidiary.
- Market cap is ~$2M, making this a micro-cap story stock with high execution risk.
Financial Impact
Flyte generated $1.0M+ in H1 2026 revenue; company guided for ~$760K in Q2 2026 Flyte revenue and 150% QoQ growth.
Risk Factors
- Parent company Catheter Precision has no disclosed revenue from its core medical device business — the entire valuation rests on the Flyte aviation subsidiary.
- Micro-cap ($2M market cap) with low liquidity — any news can cause outsized price swings.
- Forward-looking guidance of 150% QoQ revenue growth is aggressive and unverified — a miss would be severely punished.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3321274 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 9, 2026 18d ago | 8-K | $1.00 $0.8200 | ▲ +18.00% | ▲ +16.51% | $0.6500 (+35.00%) |
Oct 5, 2026 22d ago | Press Release | $1.62 $1.00 | ▼ −38.27% | ▼ −38.69% | $0.6500 (−59.88%) |
Oct 2, 2026 25d ago | 8-K | $1.62 $1.00 | ▼ −38.27% | ▼ −38.69% | $0.6500 (−59.88%) |
Oct 2, 2026 25d ago | Press Release | $1.62 $1.00 | ▼ −38.27% | ▼ −38.69% | $0.6500 (−59.88%) |
Sep 28, 2026 29d ago | Press Release | $0.1467 | awaiting T+5 | — | $0.6500 (+343.08%) |
Sep 25, 2026 4w ago | 8-K | $0.1467 | awaiting T+5 | — | $0.6500 (+343.08%) |
Aug 27, 2026 8w ago | Press Release | $0.2027 $0.1966 | ▼ −3.01% | ▼ −3.28% | $0.6500 (+220.67%) |
Aug 11, 2026 11w ago | Press Release | $0.2900 $0.2229 | ▼ −23.14% | ▼ −22.73% | $0.6500 (+124.14%) |
Aug 4, 2026 12w ago | Press Release | $0.2760 $0.2930 | ▲ +6.16% | ▲ +6.26% | $0.6500 (+135.51%) |
Jul 13, 2026 15w ago | EFFECT | $0.6504 $0.5020 | ▲ +22.82% | ▲ +21.87% | $0.6500 (+0.06%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers